The plasticity and transdifferentiation among CD4+ T cell lineages in the gut is strongly associated with IBD pathogenicity and controlled by genetic regulation of gene expression through the concerted action of cytokines, transcription factors, and epigenetic regulators. The gene discussed is CD4; the disease is inflammatory bowel disease.